n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide has been researched along with Lung Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badawi, AM; Cecchi, A; Morsy, SM; Scozzafava, A; Supuran, CT | 1 |
| Beijnen, JH; Dittrich, C; Huitema, AD; Schellens, JH; Wanders, J; Zandvliet, AS | 1 |
| Bosquee, L; Cattell, E; Ellis, P; Huitema, AD; Johnston, C; Norbury, CJ; Reck, M; Talbot, DC; von Pawel, J; Yule, SM; Zandvliet, AS | 1 |
| Fukumoto, H; Fukuoka, K; Iwamoto, Y; Nakamura, T; Narita, N; Nishio, K; Saijo, N; Usuda, J; Yoneda, T | 1 |
1 trial(s) available for n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide and Lung Neoplasms
| Article | Year |
|---|---|
A randomized phase II pharmacokinetic and pharmacodynamic study of indisulam as second-line therapy in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Female; Humans; Lung Neoplasms; Male; Middle Aged; Sulfonamides; Survival Analysis; Treatment Outcome | 2007 |
3 other study(ies) available for n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide and Lung Neoplasms
| Article | Year |
|---|---|
Carbonic anhydrase inhibitors. Biphenylsulfonamides with inhibitory action towards the transmembrane, tumor-associated isozymes IX possess cytotoxic activity against human colon, lung and breast cancer cell lines.
Topics: Antineoplastic Agents; Breast Neoplasms; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Colonic Neoplasms; Dose-Response Relationship, Drug; Female; HCT116 Cells; Humans; Isoenzymes; Lung Neoplasms; Sulfonamides | 2009 |
Population pharmacokinetic and pharmacodynamic analysis to support treatment optimization of combination chemotherapy with indisulam and carboplatin.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2008 |
Mechanisms of action of the novel sulfonamide anticancer agent E7070 on cell cycle progression in human non-small cell lung cancer cells.
Topics: Antineoplastic Agents; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Lung Neoplasms; Phosphorylation; Retinoblastoma Protein; Sulfonamides; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2001 |